tiprankstipranks
Suven Pharmaceuticals Ltd. (IN:COHANCE)
:COHANCE
India Market
COHANCE
Suven Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:COHANCE full AI Analyst Report?

Suven Pharmaceuticals Ltd. (COHANCE) Income Statement

2 Followers

Suven Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2026), Suven Pharmaceuticals Ltd.'s total revenue was ₹5.56B, an increase of 115.57% from the same quarter last year. In Q2, Suven Pharmaceuticals Ltd.'s net income was ₹740.80M. See Suven Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 22.69B₹ 11.98B₹ 10.51B₹ 13.40B₹ 13.20B
Gross Profit
₹ 9.11B₹ 8.22B₹ 6.80B₹ 7.52B₹ 7.46B
Operating Expenses
₹ 6.71B₹ 2.56B₹ 1.40B₹ 1.22B₹ 1.13B
Depreciation and Amortization
₹ 1.87B₹ 774.90M₹ 546.00M₹ 464.60M₹ 378.64M
EBITDA
₹ 4.27B₹ 4.06B₹ 4.09B₹ 5.73B₹ 5.79B
Operating Income
₹ 2.40B₹ 5.66B₹ 5.40B₹ 6.30B₹ 6.33B
Other Income/Expenses
₹ -326.20M₹ -2.22B₹ -1.34B₹ -706.22M₹ 342.03M
Pretax Income
₹ 2.07B₹ 3.44B₹ 4.06B₹ 5.60B₹ 6.68B
Net Income
₹ 1.79B₹ 2.68B₹ 3.00B₹ 4.11B₹ 4.54B
Per Share Metrics
Basic EPS
₹ 4.69₹ 10.52₹ 11.80₹ 16.16₹ 17.83
Diluted EPS
₹ 4.68₹ 10.45₹ 11.80₹ 16.16₹ 17.83
Weighted Average Shares Outstanding
 382.15M 256.44M 254.56M 254.56M 254.56M
Weighted Average Shares Outstanding (Diluted)
 382.97M 255.82M 254.56M 254.56M 254.56M
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History